Company intelligence / Profile preview

Chengdu Diao Pharmaceutical Group

Chengdu, Sichuan, China

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Chengdu Diao Pharmaceutical Group is a leading Chinese integrated pharmaceutical company with a strong focus on R&D and manufacturing of both traditional Chinese medicines and innovative therapeutics. The company has multiple approved drugs in China, including small molecules and biologics for cardiovascular, hematological, metabolic, and nervous system diseases. It also has ongoing clinical programs targeting obesity and other indications

Therapeutic areas: HematologyEndocrinologyCardiovascular
Modalities: Small moleculeHerbal medicineAntisense oligonucleotideColony-stimulating factorsRecombinant protein
Industry: Biotech

Partnerships

none publicly disclosed; participates in international forums such as ACCESS CHINA BD Forum @BIO

Beyond the preview

Go deeper on Chengdu Diao Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chengdu Diao Pharmaceutical Group.

Explore the full profile